Fungal coinfection/superinfection in COVID-19 patients in a tertiary hospital in Mexico.

Introduction: Data on the prevalence of fungal coinfections/superinfections in patients with COVID-19 are limited.

Objective: To describe the prevalence of fungal coinfections/superinfections in patients with COVID-19, as well as risk factors and demographic, clinical, and microbiological characteristics.

Material And Methods: We included patients with a confirmed COVID-19 diagnosis and a confirmed fungal infection hospitalized in the ICU from March 2020 to December 2021.

Evaluation of Primers OPF-01, P54, and 1253 to Identify , , and from Polymorphic Patterns Obtained by RAPD-PCR.

We evaluated the specificity of the primers OPF-01, P54, and 1253 to identify , , and , respectively, with the RAPD-PCR method. Eighty-two isolates belonging to the sections , , and were used. The isolates were identified by phenotypic (macro- and micromorphology) and genotypic (partial sequences of the gene) methods.

Development of SCAR Markers for Genetic Authentication of .

In this study, molecular typing using Randomly Amplified Polymorphic DNA (RAPD-PCR) was conducted on 16 original isolates of obtained from locusts ( ssp. .) in Mexico (MX).

Clinical Cases of Coccidioidomycosis in the Americas in the Period 1950-2021: Epidemiology Data, Diagnosis, and Treatment.

Coccidioidomycosis, caused by and , causes significant morbidity and mortality, both in immunocompetent and immunocompromised people, mainly in endemic areas. The present work analyzed its epidemiology, diagnostic methods, and treatment by reviewing clinical cases published from 1950 to 2021. Fifty-nine articles were included, corresponding to 275 clinical cases.